中华皮肤科杂志 ›› 2009, Vol. 42 ›› Issue (2): 101-104.

• 论著 • 上一篇    下一篇

BRAFV600E突变基因对人黑素瘤细胞侵袭能力影响的研究

陈浩 张玲 薛燕宁 韩永智 徐秀莲 曾学思 孙建方   

  1. 南京中国医学科学院中国协和医科大学皮肤病研究所 南京医科院皮研所 广州市广东省人民医院皮肤科 南京医科院皮研所 南京医科院皮研所 南京医科院皮研所
  • 收稿日期:2008-02-21 修回日期:2008-05-12 出版日期:2009-02-15 发布日期:2009-02-15
  • 通讯作者: 陈浩 E-mail:ch76ch@Yahoo.com.cn

Effects of BRAFV600E mutation on the invasion capacity of human melanoma cells

  • Received:2008-02-21 Revised:2008-05-12 Online:2009-02-15 Published:2009-02-15

摘要:

目的 探讨BRAFV600E突变基因对黑素瘤细胞侵袭能力的影响。方法 用构建成功的质粒载体转染人黑素瘤细胞株A375,在体外干扰BRAFV600E突变基因,用Transwell小室检测肿瘤细胞侵袭能力,用明胶酶法检测基质金属蛋白酶-2(MMP-2)的变化,采用RT-PCR和Western印迹检测MMP-2和血管内皮细胞生长因子(VEGF)mRNA和蛋白表达。结果 特异性短发卡RNA抑制人黑素瘤细胞MMP-2和VEGF mRNA和蛋白的表达,MMP-2 mRNA和蛋白表达分别减少35%和80%,VEGF则减少45%和14%。转染特异性质粒的黑素瘤细胞穿过Metrigel的数目下降69%。结论 BRAFV600E突变增强黑素瘤细胞的侵袭能力,特异性shRNA可以使瘤细胞的侵袭性下降。 

关键词: shRNA;黑素瘤;BRAF基因;RNA干扰

Abstract:

Objective To investigate the effect of BRAFV600E mutation on the invasion capacity of a human melanoma cell line, A375. Methods Plasmids containing short hairpin RNAs (shRNA) specific for BRAF gene were prepared in previous study, and used to transfect A375 cells. Those cells transfected with negative plasmid and untransfected cells served as the controls. Transwell chambers were used to examine the invasion ability of melanoma cells in vitro. RT-PCR and Western blotting were performed to detect the mRNA and protein expressions of matrix metalloproteinase 2 (MMP-2) and vascular endothelial growth factor (VEGF), respectively, before and after the transfection. The activity of MMP-2 was also studied with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Results Compared with the negative control, the specific shRNA decreased the mRNA and protein expressions of MMP-2 by 35% and 85%, respectively, and those of VEGF by 45% and 14%, respectively. Additionally, the number of cells invading through Matrigel chambers reduced by 69% in those cells transfected with the positive plasmid. Conclusions The mutant BRAFV600E has the potential to enhance the invasion capacity of melanoma cells, whereas specific shRNA could suppress the increase in metastasis capacity likely by inhibiting the production of VEGF and MMP.

Key words: shRNA;melanoma;BRAF;MMP-2;VEGF